Connect your AI

eXoZymes, Inc. EXOZ Q1 2026 earnings

Reported May 14, 2026 · Before market open

Diluted EPS-$0.28

Next report

Date not yet announced

Financials

Q1 2026

Income statement

Operating income-$2.4M-22.4%

Net income-$2.4M-27.7%

EPS (diluted)-$0.28-27.3%

Balance sheet

Cash & equivalents$1.4M-83.0%

Total debt$1.2M-8.8%

Total equity$1.5M-82.8%

Total assets$4.0M-65.1%

Cash flow

Operating cash flow-$1.5M-34.5%

CapEx$57.6K+85.5%

Free cash flow-$1.6M-35.8%

Valuation & ratios

Valuation

as of 07/10/26

Market cap$65.71M—

Enterprise value$65.48M—

Returns & leverage

Return on equity-185.8%—

Debt / equity0.8×+0.6×

Current ratio1.3×-5.2×

Versus estimates

Diluted EPS

Q1 2026-$0.28

Q4 2025-$0.32 Q3 2025-$0.27 Q2 2025-$0.28 Q1 2025-$0.22

Ask the moment eXoZymes, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk

Questions, answered.

When did eXoZymes, Inc. report Q1 2026 earnings?: eXoZymes, Inc. (EXOZ) reported Q1 2026 earnings on May 14, 2026 before market open.
What were eXoZymes, Inc.'s Q1 2026 revenue and EPS?: eXoZymes, Inc. reported diluted EPS of $-0.28 for Q1 2026.
How did eXoZymes, Inc.'s Q1 2026 results compare year-over-year?: Compared to the same quarter a year prior, diluted EPS declined 27.3% from $-0.22.
Where can I find eXoZymes, Inc.'s Q1 2026 SEC filings?: You can read the 10-Q periodic report (0001493152-26-023035) directly on SEC EDGAR. The filing index links above go to sec.gov.